{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:20:33Z","timestamp":1762078833856,"version":"3.38.0"},"reference-count":37,"publisher":"American Veterinary Medical Association (AVMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To evaluate inhibitory effects of synthetic matrix metalloproteinase (MMP) inhibitors in vitro on gelatinolytic and collagenolytic activities in tracheal epithelial lining fluid (TELF) of horses with recurrent airway obstruction (RAO).<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u201410 horses with RAO and 5 healthy control horses.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Substrate-based functional assays, collagen I and gelatin degradation, were used to measure endogenous collagenolytic and gelatinolytic activities in TELF. In vitro inhibition of MMP activity in TELF with 2 chemically modified tetracyclines (CMTs; CMT-3 and CMT-8) and 2 bisphosphonates (BPs; zoledronate and pamidronate) was evaluated.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014CMT-3, CMT-8, zoledronate, and pamidronate in a dose-dependent manner inhibited TELF type I collagenolytic and gelatinolytic activities, although no complete inhibition of TELF type I collagenolytic and gelatinolytic activities was achieved with the inhibitor concentrations of 25 to 500\u03bcM tested. The CMTs inhibited pathologically induced collagen I degradation more effectively than BPs. Of the tested CMTs, CMT-3 was the most effective inhibitor of gelatinolytic activity, and the efficiency of CMT-3 corresponded with that of the BPs.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014An increase in MMP activity in the equine respiratory tract may potentially be inhibited by administration of CMTs or BPs. Distinct synthetic MMP inhibitors may eventually provide an additional means for pharmacologic treatment by decreasing ongoing active tissue destructive inflammation associated with chronic lung disease. The MMP inhibitors such as CMTs and BPs that are targeted to solely inhibit a pathologic increase in MMP activities provide the advantage of minimal adverse effects that are characteristics of other excessively potent MMP inhibitors.<\/jats:p>","DOI":"10.2460\/ajvr.67.7.1252","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T16:45:30Z","timestamp":1152204330000},"page":"1252-1257","source":"Crossref","is-referenced-by-count":7,"title":["In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction"],"prefix":"10.2460","volume":"67","author":[{"given":"Saara M.","family":"Raulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Maisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Equine Vet Educ","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.2042-3292.1992.tb01637.x","article-title":"Tracheal wash sampling in the horse","volume":"4","author":"Roberts","year":"1992"},{"key":"ref2","series-title":"Equine Vet J","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.2042-3306.1995.tb04421.x","article-title":"Equine pulmonary disease: a case control study of 300 referred cases. Parts 1, 2 and 3","volume":"27","author":"Dixon","year":"1995"},{"key":"ref3","series-title":"Br Vet J","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0007-1935(96)80101-1","article-title":"The pathogenesis of chronic obstructive pulmonary disease of horses","volume":"152","author":"Robinson","year":"1996"},{"key":"ref4","series-title":"Exp Lung Res","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/01902148809087827","article-title":"Neutrophil response following intratracheal instillation of collagen peptides into rat lungs","volume":"14","author":"Riley","year":"1988"},{"key":"ref5","series-title":"Ann Med","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/07853899909019260","article-title":"Matrix metalloproteinases and their inhibitors in tumour growth and invasion","volume":"31","author":"K\u00e4h\u00e4ri","year":"1999"},{"key":"ref6","series-title":"Oral Dis","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1601-0825.2004.01038.x","article-title":"Matrix metalloproteinases (MMPs) in oral diseases","volume":"10","author":"Sorsa","year":"2004"},{"key":"ref7","series-title":"Acta Vet Scand","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/BF03548503","article-title":"Collagenolytic activity and its sensitivity to doxycycline inhibition in tracheal aspirates of horses with chronic obstructive pulmonary disease","volume":"38","author":"Koivunen","year":"1997"},{"key":"ref8","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2460\/ajvr.2001.62.1142","article-title":"Evaluation of collagenase activity, matrix metalloproteinase-8 and -13 in horses with COPD","volume":"62","author":"Raulo","year":"2001"},{"key":"ref9","series-title":"Nat Rev Cancer","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002"},{"key":"ref10","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.4049\/jimmunol.172.12.7791","article-title":"Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase","volume":"172","author":"Owen","year":"2004"},{"key":"ref11","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.4049\/jimmunol.175.4.2589","article-title":"Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation","volume":"175","author":"Gueders","year":"2005"},{"key":"ref12","series-title":"Am J Vet Res","first-page":"818","article-title":"Gelatinolytic activity in tracheal epithelial lining fluid and in blood from horses with chronic obstructive pulmonary disease","volume":"59","author":"Raulo","year":"1998"},{"key":"ref13","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2460\/ajvr.2000.61.1067","article-title":"Concentrations of elastinolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease","volume":"61","author":"Raulo","year":"2000"},{"key":"ref14","series-title":"Equine Vet J","first-page":"128","article-title":"MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar lavage fluid (BALF) of COPD horses","volume":"33","author":"Raulo","year":"2001"},{"key":"ref15","series-title":"Equine Vet J","first-page":"150","article-title":"Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses","volume":"34","author":"Nevalainen","year":"2002"},{"key":"ref16","series-title":"Equine Vet J","first-page":"155","article-title":"Dose responses to inhalation of endotoxin, hay dust suspension and Aspergillus fumigatus extract in horses as measured by levels and activation of matrix metalloproteinase-9","volume":"37","author":"Simonen-Jokinen","year":"2005"},{"key":"ref17","series-title":"Am J Respir Crit Care Med","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1164\/ajrccm.159.4.9708080","article-title":"Contribution of 92kDa gelatinase\/type IV collagenase in bronchial inflammation during status asthmaticus","volume":"159","author":"Lemjabbar","year":"1999"},{"key":"ref18","series-title":"J Periodontal Res","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observation and a proposed new mechanism of action","volume":"18","author":"Golub","year":"1983"},{"key":"ref19","series-title":"J Dent Res","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/00220345870660080401","article-title":"A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity","volume":"66","author":"Golub","year":"1987"},{"key":"ref20","series-title":"Ann N Y Acad Sci","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1749-6632.1999.tb07759.x","article-title":"MMP inhibition by chem ically modified tetracycline-3 (CMT-3) in equine pulmonary epithelial lining fluid","volume":"878","author":"Maisi","year":"1999"},{"key":"ref21","series-title":"J Dent Res","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1177\/00220345970760090401","article-title":"Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate","volume":"76","author":"Teronen","year":"1997"},{"key":"ref22","series-title":"Anticancer Drugs","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00001813-200203000-00006","article-title":"Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines","volume":"13","author":"Heikkil\u00e4","year":"2002"},{"key":"ref23","series-title":"Ann N Y Acad Sci","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1749-6632.1999.tb07702.x","article-title":"MMP inhibition and downregulation by bisphosphonates","volume":"878","author":"Teronen","year":"1999"},{"key":"ref24","series-title":"Am J Vet Res","first-page":"729","article-title":"Hyaluronate concentration in tracheal lavage fluid from clinically normal horses and horses with chronic obstructive pulmonary disease","volume":"58","author":"Tulamo","year":"1997"},{"key":"ref25","series-title":"Methods of enzymatic analysis","first-page":"1794","article-title":"Determination of urea with glutamate dehydrogenase as indicator enzyme","author":"Guttmann","year":"1994"},{"key":"ref26","series-title":"J Appl Physiol","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution","volume":"60","author":"Rennard","year":"1986"},{"key":"ref27","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0076-6879(82)82059-4","article-title":"Preparation and characterization of the different types of collagen","author":"Miller","year":"1982"},{"key":"ref28","series-title":"Chest","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1378\/chest.106.4.1129","article-title":"Gelatinolytic and type IV collagenolytic activity in bronchiectasis","volume":"106","author":"Sepper","year":"1994"},{"key":"ref29","series-title":"Curr Opin Dent","first-page":"80","article-title":"Host modulation with tetracyclines and their chemically-modified non-antimicrobial derivatives","volume":"2","author":"Golub","year":"1992"},{"key":"ref30","series-title":"Ann N Y Acad Sci","first-page":"112","article-title":"Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases","volume":"732","author":"Sorsa","year":"1994"},{"key":"ref31","series-title":"J Bone Miner Res","first-page":"1247","article-title":"Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase","volume":"8","author":"Ramamurthy","year":"1993"},{"key":"ref32","series-title":"Res Commun Mol Pathol Pharmacol","first-page":"151","article-title":"Comparison of doxycycline and a chemically modified tetracycline inhibition of leukocyte functions","volume":"78","author":"Gabler","year":"1992"},{"key":"ref33","series-title":"Adv Dent Res","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998"},{"key":"ref34","series-title":"J Rheumatol","first-page":"975","article-title":"Functional sites of chemically modified tetracyclines, inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases","volume":"25","author":"Sorsa","year":"1998"},{"key":"ref35","series-title":"Inflamm Res","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s000110050193","article-title":"A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis","volume":"46","author":"Golub","year":"1997"},{"key":"ref36","series-title":"J Biol Chem","first-page":"5872","article-title":"Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3\/4- and 1\/4-length fragments","volume":"270","author":"Aimes","year":"1995"},{"key":"ref37","series-title":"J Periodontol","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1902\/jop.2001.72.8.1069","article-title":"A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin induced periodontal breakdown in rats","volume":"72","author":"Llavaneras","year":"2001"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/7\/ajvr.67.7.1252.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/7\/ajvr.67.7.1252.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/7\/ajvr.67.7.1252.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:15:21Z","timestamp":1741349721000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/7\/ajvr.67.7.1252.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":37,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.67.7.1252","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}